New combo pill aims to tackle diabetes and hypertension at once
NCT ID NCT06647745
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This Phase 3 trial tests whether taking dapagliflozin and telmisartan together works better than either drug alone for people with type 2 diabetes and high blood pressure. About 221 adults will receive either the combo or a single drug for 12 weeks. Researchers will measure changes in blood sugar and blood pressure to see if the combination is more effective and safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dapagliflozin and telmisartan
What this could lead to
If successful, this combination could offer a more effective, single-pill option to control both blood sugar and blood pressure in people with type 2 diabetes and hypertension.
What could go wrong
This is a Phase 3 trial, but results may not apply to everyone. Side effects from the drugs (e.g., dehydration, low blood pressure) are possible. The combo may not prove superior to taking each drug alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Thammasat University Hospital
NOT_YET_RECRUITINGPathum Thani, Changwat Pathum Thani, 12120, Thailand
Contact
-
The Catholic University of Korea, Yeouido ST. Mary's Hospital
RECRUITINGSeoul, 07345, South Korea
Contact